Sergio Ermotti to be nominated for election to Swiss Re’s board of directors
Swiss Re’s board of directors will nominate Sergio Ermotti for election as a new, non-executive and independent member of the board at the upcoming Annual General Meeting of shareholders (AGM) on 17 April 2020 for a one-year term of office, the company has said. In 2021 he will be nominated to succeed Walter Kielholz as chairman of the board.
Sergio Ermotti has been group chief executive officer and a member of the group executive board of UBS Group since 2011. Before joining UBS, he was group deputy chief executive officer at UniCredit and responsible for the business areas of corporate and investment banking, and private banking between 2007 and 2010. He started his professional career at Merrill Lynch in 1987, where he held various positions in the areas of equity derivatives and capital markets before he became co-head of Global Equity Markets and a member of the executive management committee for Global Markets & Investment Banking in 2001.
Swiss Re’s chairman of the board of directors Walter Kielholz said: “With the nomination of Sergio Ermotti, we are pleased to be able to propose such an accomplished financial industry leader as a new board member and future Chairman. Sergio Ermotti’s wealth of experience and an impressive leadership track-record will be important assets for Swiss Re. His appointment will ensure a smooth leadership transition when I retire after the AGM in 2021, and I look forward to working closely with him until then.”
Sergio Ermotti said: “As a company centred around knowledge and risk expertise, Swiss Re is a truly inspirational financial institution. I look forward to working together with the board and the management team to take the company into the next successful chapter of its history. I am honoured to be following in the footsteps of Walter Kielholz, who over the past decades immensely furthered the development not only of Swiss Re, but the entire Swiss financial centre.”
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze